Spiriva Finds COPD Exacerbation Studies Can Be An Exasperating Experience
This article was originally published in The Pink Sheet Daily
Executive Summary
As competitors tout comparative data, Boehringer hopes a Nov. 19 advisory committee on its claim for reduction in exacerbations will lead to a broader label.